Cadrenal Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | ||||
EBITDA | -3,339 | -2,495 | -3,038 | -2,685 |
EBIT | -3,340 | -2,496 | -3,038 | -2,685 |
Net Income | -3,322 | -2,496 | -3,038 | -2,685 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,233 | -3,002 | -2,569 | -2,359 |
Cash | 2,388 | 2,308 | 4,007 | 3,860 |
Basic Shares | 2,913 | 2,407 | 1,993 | 2,044 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -1 | -1 | |
EBITDA | -13,230 | -10,649 | -8,338 |
EBIT | -13,237 | -10,651 | -8,339 |
Net Income | -13,237 | -10,651 | -8,357 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -12,601 | -7,364 | -3,533 |
Cash | 4,007 | 10,017 | 8,402 |
Basic Shares | 1,993 | 1,219 | 868 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.14 |
2026-03-31 | -$1.04 |
2025-12-31 | -$1.41 |
2025-09-30 | -$1.31 |